跳至主要内容
临床试验/NCT05537727
NCT05537727已完成不适用

Robotic Minimally Invasive Gynecological, Urological, and General Surgery With Dexter

Distalmotion SA5 个研究点 分布在 3 个国家目标入组 100 人开始时间: 2022年9月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
5
主要终点
occurrence of serious (Clavien - Dindo grades III-V), device related adverse events.

研究概览

简要总结

The purpose of this study is to confirm the perioperative and early postoperative safety and clinical performance of the Dexter Robotic System (Dexter Surgical System, Model DM-L6).

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged ≥ 18 years
  • Patient agrees to perform the 30-day follow-up assessment
  • Able to provide signed Informed Consent, according to local regulation

排除标准

  • Morbidly obese patients.
  • Any and all relative and absolute contraindications to endoscopic surgical technique applicable to the use of conventional endoscopic surgical instruments.
  • Bleeding diathesis.
  • Pregnancy.
  • Patients with pacemakers or internal defibrillators.
  • Any planned concomitant procedures.
  • Patient deprived of liberty by administrative or judicial decision or under legal guardianship.
  • Participation in another interventional clinical trial.

结局指标

主要结局

occurrence of serious (Clavien - Dindo grades III-V), device related adverse events.

时间窗: perioperatively up to 30 days

successful completion of the Dexter-assisted procedure, i.e. free of any device related permanent conversion to an open or fully laparoscopic surgical approach.

时间窗: intraoperative

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验